Duration of Ictal Hypoxemia is Associated With Potentially High-Risk Cardiac Arrhythmias in EpilepsyDecember 06, 2017
Duration of ictal/postictal hypoxemia may be associated with potentially high-risk cardiac arrhythmias during FBTCSs/GTCSs.
The drug is the first and only IV formulation of the antiepileptic carbamazepine.
The drug's pediatric exclusivity expires in March 2017.
Surgery had a significant impact on mortality even if seizures were not completely eliminated.
The Brain Sentinel device was as sensitive as vEEG review by an epileptologist for seizure detection.
Heart rate, arterial oxygenation, and electrodermal activity improved accuracy compared with heart rate alone.
Inhibiting the pathway upstream of mTOR at the level of PI3K signaling, a locus of significant molecular crosstalk in this pathway, restored the seizure-induced learning and memory deficits.
3D printing technology is used to create a porous drug that disintegrates rapidly with just a sip of liquid.
Treatment with in-MDZ reduced frequency of subsequent and generalized tonic-clonic seizure.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans